Glucuronidation and sulfation of 7-hydroxycoumarin in liver matrices from human, dog, monkey, rat, and mouse

In Vitro Cellular and Developmental Biology - Animal

Volumn 41, Issue 3-4, 2005, Pages 97-103

  Wang, Qing ^a   Jia, Richard ^a   Ye, Cindy ^a   Garcia, Martha ^a   Li, Jibin ^a   Hidalgo, Ismael J ^a  

^a Absorption Systems   (United States)

Author keywords

In vitro; Metabolism; Model; Phase II

Indexed keywords

GLYCOSYLTRANSFERASE; SULFOTRANSFERASE; UMBELLIFERONE; UNCLASSIFIED DRUG; URIDINE 5' DIPHOSPHO N ACETYLGALACTOSAMINE GLYCOSYLTRANSFERASE; URIDINE DIPHOSPHATE N ACETYLGALACTOSAMINE;

ANIMAL CELL; ARTICLE; DOG; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG SULFATION; FEMALE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER CELL; LIVER MICROSOME; MALE; MONKEY; MOUSE; NONHUMAN; RAT; TANDEM MASS SPECTROMETRY;

ANIMALS; CELLS, CULTURED; CRYOPRESERVATION; DOGS; HAPLORHINI; HEPATOCYTES; HUMANS; KINETICS; LIVER; MICE; MICROSOMES, LIVER; RATS; SULFOTRANSFERASES; UMBELLIFERONES;

CANIS FAMILIARIS; MACACA FASCICULARIS;

EID: 22344449177     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1290/0501005.1     Document Type: Article

References (28)

1. Abbott, F. V.; Palmour, R. M. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 43(21):1685-1695: 1988.
2. Bock, K. W. Vertebrate UDP-glucuronosyltansferases: functional and evolutionary aspects. Biochem. Pharmacol. 66(5):691-696: 2003.
3. Donato, M. T.; Castell, J. V. Strategies und molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin. Pharmacokinet. 42(2):153-178: 2003.
4. Ekins, S.; Murray, G. I.; Burke, M. D.; Williams, J. A.; Marchant, N. C.; Hawksworth, G. M. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug Metab. Dispos. 23(11):1274-1279: 1995.
5. Ekins, S.; Williams, J. A.; Murray, G. I.; Burke, M. D.; Marchant, N. C.; Eugeset, J.; Hawksworth, G. M. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices. Drug Metab. Dispos. 24(9):990-995: 1996.
6. Falany, C. N.; Kerl, E. A. Sulfation of minoxidil by human liver phenol sulfotransferase. Biochem. Pharmacol. 40(5):1027-1032: 1990.
7. Farrell, D. F.; McKbann, G. M. Characterization of cerebroside sulfotransferase from rat brain. J. Biol. Chem. 246(15):4694-4702: 1971.
8. Garcia, M.; Rager, J.; Wang, Q.; Strab, R.; Hidalgo, I. J.; Owen, A.; Li, J. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies. In Vitro Cell. Dev. Biol. 39A(7):283-287: 2003.
9. Gervasini, G.; Carrillo, J. A.; Benitez, J. Potential role of cerebral cytochrome p450 in clinical pharmacokinetics: modulation by endogenous compounds. Clin. Pharmacokinet. 43(11):693-706: 2004.
10. Goldstein, J. A.; Faletto, M. B. Advances in mechanisms of activation and deactivation of environmental chemicals. Environ. Health Perspect. 100:169-176: 1993.
11. Hauser, S. C.; Ziurys, J. C.; Gollan, J. L. A membrane transporter mediates access of uridine 5′-diphosphoglucuronic acid from the cytosol into the endoplasmic reticulum of rat hepatocytes: implications for glucuronidation reactions. Biochim. Biophys. Acta 967(2):149-157: 1988.
12. Hengstler, J. G.; Utesch, D.; Steinberg, P., et al. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab. Rev. 32(1):81-118: 2000.
13. Iyer, K. R.; Sinz, M. W. Characterization of phase I and phase II hepatic drug metabolism activities in a panel of human liver preparations. Chem. Biol. Interact. 118(2):151-169: 1999.
14. Klaassen, C. D.; Liu, L.; Dunn, R. T., II. Regulation of sulfotransferase mRNA expression in male and female rats of various ages. Chem. Biol. Interact. 109(1-3):299-313: 1998.
15. Mackenzie, P. I.; Owens, I. S.; Burchell, B., et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature: update based on evolutionary divergence. Pharmacogenetics 7(4):255-269: 1997.
16. Muraoka, M.; Kawakita, M.; Ishida, N. Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity. FEBS Lett. 495(1-2):87-93: 2001.
17. Otake, Y.; Hsieh, F.; Walle, T. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab. Dispos. 30(5):576-581: 2002.
18. Ouyang, Y.; Lane, W. S.; Moore, K. L. Tyrosylprotein sulfotransferase: purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins. Proc. Natl. Acad. Sci. USA 95(6):2896-2901: 1998.
19. Ouyang, Y. B.; Moore, K. L. Molecular cloning and expression of human and mouse tyrosylprotein sulfotransferase-2 and a tyrosylprotein sulfotransferase homologue in Caenorhabditis elegans. J. Biol. Chem. 273(38):24770-24774: 1998.
20. Ranchschwalbe, S. K.; Zuhlsdorf, M. T.; Wensing, G.; Kuhlmann, J. Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype. Int. J. Clin. Pharmacol. Ther. 42(2):73-77: 2004.
21. Roymans, D.; Van Looveren, C.; Leone, A., et al. Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes. Biochem. Pharmacol. 67(3):427-437: 2004.
22. Sharer, J. E.; Shipley, L. A.; Vaudenbranden, M. R.; Binkley, S. N.; Wrighton, S. A. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metab. Dispos. 23(11):1231-1241: 1995.
23. Snodgrass, B.; Gagne, P.; Picano, P., et al. Comparison of major phase I and phase II metabolism reactions in cryopreserved dog and human hepatocytes. Drug Metab. Rev. 35(S2): Abstract 73. 2003. URL: http://www.dekker.com/servlet/ product/DOI/101081DMR120026877.
24. Swales, N. J.; Utesch, D. Metabolic activity of fresh and cryopreserved dog hepatocyte suspensions. Xenobiotica 28:937-948: 1998.
25. Tephly, T. R.; Burchell, B. UDP-glucuronyltransferases: a family of detoxifying enzymes. Trends Pharmacol. Sci. 11:276-279: 1990.
26. Trohan, S.; Zurich, M. C.; Chung, H.; Weiner, M.; Kane, A. S.; Rosen, G. M. Tissue slices revisited: evaluation and development of a short-term incubation for integrated drug metabolism. Drug Metab. Dispos. 29(10):1337-1342: 2001.
27. Vaidyanathan, J. B.; Walle, T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab. Dispos. 30(8):897-903: 2002.
28. Weinsbilboum, R. M.; Otteruess, D. M.; Aksoy, I. A.; Wood, T. C.; Her, C.; Raftogianis, R. B. Sulfation and sulfotransferases 1: sulfotransferase molecular biology: cDNAs and genes. FASEB J. 11(1):3-14: 1997.